Outcome of a Triple Inner Branched Aortic Arch Stentgraft. A Prospective, Multicenter Registry.
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorUniversity Hospital Muenster
About this trial
Outcome of a triple inner branched aortic arch stentgraft. A prospective, mulitcenter registry.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
18 years or older
Presence of Aortic arch pathology
Treatment planned with triple inner branch from Terumo Aortic
Availability of the patients during the follow up period
Disqualifiers
Women of childbearing age
Patients under 18 years
Trial population
Study participants will be recruited from patients presenting to participating hospitals with aortic pathology and meeting inclusion and exclusion criteria.
Trial design
Design model
Other
Time perspective
Prospective
Treatments tested in this trial
Triple inner branched arch stentgraft
DeviceNew findings regarding treatment planning and management of patients with aortic arch pathologies.
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
Mortality
Time frame
30 days after intervention2
feasibility in terms of cannulation and stentgrafting of the three branches
Time frame
During intervention3
Stroke
Time frame
30 days after interventionSecondary outcomes
1
Morbidity
Access issue, paraplegia, kidney failure
Time frame
during the follow up period of 3 year2
Endoleaks Type I and III
Time frame
during intervention and the follow up period of 3 year3
Longterm mortality
Time frame
during the follow up period of 3 year4
Patency rate of branches
primary and secondary
Time frame
during the follow up period of 3 yearSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov